APOE genotypes and polygenic genetic burdens for Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia were obtained through genome-wide genotyping. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.